CAS 856676-23-8
:Choline fenofibrate
Description:
Choline fenofibrate is a pharmaceutical compound that combines choline, a nutrient essential for various bodily functions, with fenofibrate, a lipid-regulating agent primarily used to treat hyperlipidemia. This compound is characterized by its ability to enhance lipid metabolism and reduce triglyceride levels in the bloodstream. Choline fenofibrate functions by activating peroxisome proliferator-activated receptors (PPARs), which play a crucial role in fatty acid oxidation and lipoprotein metabolism. The presence of choline in this compound may also contribute to its potential neuroprotective effects and support cognitive function. In terms of solubility, choline fenofibrate is generally more soluble in organic solvents than in water, which can influence its bioavailability and absorption in the body. The compound is typically administered in a controlled dosage form to ensure therapeutic efficacy while minimizing side effects. As with any medication, it is essential to consider potential interactions with other drugs and individual patient factors when prescribing choline fenofibrate.
Formula:C22H28ClNO5
InChI:InChI=1/C17H15ClO4.C5H14NO/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11;1-6(2,3)4-5-7/h3-10H,1-2H3,(H,20,21);7H,4-5H2,1-3H3/q;+1/p-1
SMILES:CC(C)(C(=O)O)Oc1ccc(cc1)C(=O)c1ccc(cc1)Cl.CN(C)(C)CCO
Synonyms:- 2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid
- 2-Hydroxy-N,N,N-trimethylethanaminium 2-(-(4-chlorobenzoyl)phenoxy)-2- methylpropanoate
- Abt 335
- Fenofibrate de choline
- Trilipix
- Unii-4Bmh7Izt98
- Ethanaminium, 2-hydroxy-N,N,N-trimethyl-, salt with 2-(4-(4- chlorobenzoyl)phenoxy)-2-methylpropanoic acid (1:1)
- 2-hydroxy-N,N,N-trimethylethanaminium 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
Choline Fenofibrate (2-Hydroxy-N,N,N-trimethylethanaminium 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate)
CAS:<p>Choline and its salts</p>Formula:C17H14ClO4·C5H14NOColor and Shape:White PowderMolecular weight:421.91 g/mol2-Hydroxy-N,N,N-Trimethylethanaminium 2-(4-(4-Chlorobenzoyl)Phenoxy)-2-Methylpropanoate
CAS:<p>2-Hydroxy-N,N,N-Trimethylethanaminium 2-(4-(4-Chlorobenzoyl)Phenoxy)-2-Methylpropanoate</p>Purity:98%Molecular weight:421.91g/molCholine Fenofibrate (CFRC-3)
CAS:Formula:C17H14ClO4·C5H14NOColor and Shape:White To Off-White SolidMolecular weight:317.75 104.17Choline Fenofibrate
CAS:<p>Choline Fenofibrate (Trilipix) is a choline formulation of fenofibrate, a synthetic phenoxy-isobutyric acid derivate and prodrug with antihyperlipidemic</p>Formula:C22H28ClNO5Purity:98.82%Color and Shape:SolidMolecular weight:421.91Choline Fenofibrate
CAS:Controlled Product<p>Applications A new formulation of fenofibric acid, ABT-335, co-administered with statins.<br>References Athyros, V., et al.: Diabetes Care, 25, 1198 (2002), Sacks, F., et al.: Am. J. Cardiol., 90, 139 (2002), Wierzbicki, A., et al.: Curr. Med. Res. Opin., 19, 155 (2003), Sarwar, N., et al.: Circulation, 115, 450 (2007),<br></p>Formula:C17H14ClO4·C5H14NOColor and Shape:NeatMolecular weight:421.91Choline Fenofibrate-d6
CAS:Controlled Product<p>Applications Choline Fenofibrate-d6 is the labeled analogue of Choline Fenofibrate (C432665), a new formulation of fenofibric acid, ABT-335, co-administered with statins.<br>References Athyros, V., et al.: Diabetes Care, 25, 1198 (2002); Sacks, F., et al.: Am. J. Cardiol., 90, 139 (2002); Wierzbicki, A., et al.: Curr. Med. Res. Opin., 19, 155 (2003); Sarwar, N., et al.: Circulation, 115, 450 (2007)<br></p>Formula:C17D6H8ClO4·C5H14NOColor and Shape:NeatMolecular weight:427.951






